Mediating its effects by binding to its major corresponding receptor, CXCR4, CXCL12 is implicated in inflammatory responses, autoimmune diseases, T cell homing, angiogenesis, CAFs activation, EMT, tumor progression, metastasis, and therapy resistance [199,200,201,202]. The gene discussed is CXCL12; the disease is neoplasm.